Published in

Taylor and Francis Group, Expert Review of Clinical Pharmacology, 8(13), p. 807-811, 2020

DOI: 10.1080/17512433.2020.1798760

Links

Tools

Export citation

Search in Google Scholar

Could a specific ACE2 activator drug improve the clinical outcome of SARS-CoV-2? A potential pharmacological insight

Journal article published in 2020 by Lucas A. D. Nicolau ORCID, Isabela R. S. G. Nolêto, Jand V. R. Medeiros ORCID
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO